Symbol
CASI on Nasdaq
Investment type
Equity / Ordinary Share
Latest Disclosed Ownership
980K shares
Security Ownership
6.3%

Foresite Capital Fund VI LP ownership in CASI Pharmaceuticals, Inc. Ordinary Share (CASI)

2025-11-14 - Foresite Capital Fund VI LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 980K shares of CASI Pharmaceuticals, Inc. Ordinary Share (CASI). This represents 6.3% percent ownership of the company. In their previous filing dated 2025-08-12, Foresite Capital Fund VI LP had reported owning 787K shares, indicating an increase of 24.5% percent.